BMS-986253 in Myelodysplastic Syndromes
Clinical trial NCT05148234 · TERMINATED
Trial details
- NCT number
- NCT05148234
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-29
- Primary completion
- 2023-02-02
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.